Related Experiment Videos
Chronic infections and coronary heart disease
1Department of Cardiological Sciences, St George's Hospital Medical School, London, UK.
Insights
Infectious agents like Chlamydia pneumoniae may contribute to coronary heart disease (CHD) and atherosclerosis. Antibiotic interventions show promise for treating CHD, suggesting infection plays a role.
Area of Science:
- Cardiovascular Medicine
- Infectious Diseases
- Pathogenesis of Atherosclerosis
Background:
- Conventional cardiovascular risk factors do not fully explain coronary heart disease (CHD) prevalence.
- Infectious agents are increasingly implicated in the development of atherosclerosis.
- Chlamydia pneumoniae shows the strongest evidence linking infection to CHD.
Purpose of the Study:
- To investigate the role of infectious agents, specifically Chlamydia pneumoniae, in the etiology of coronary heart disease.
- To evaluate the potential of anti-chlamydia antibiotic interventions for CHD treatment.
Main Methods:
- Review of sero-epidemiological, pathological, and animal-model studies.
- Analysis of results from pilot antibiotic intervention studies targeting Chlamydia pneumoniae.
Main Results:
- Evidence suggests Chlamydia pneumoniae is associated with atherosclerosis and CHD.
- Pilot antibiotic studies targeting Chlamydia pneumoniae have shown promising results.
- Ongoing larger intervention studies are expected to provide further insights.
Conclusions:
- Infection, particularly with Chlamydia pneumoniae, may be a contributing factor to atherogenesis.
- Broad-spectrum antibiotics could represent a novel treatment strategy for coronary heart disease patients.
Abstract:
The rapidly changing patterns of coronary heart disease (CHD) prevalence and presentation fail to be explained by conventional cardiovascular risk factors alone. An infectious basis to atherosclerosis may, at least in part, be contributing to the variable rates of prevalence of CHD in different parts of the world. The evidence for such an association appears to be strongest for Chlamydia pneumoniae. Results of recent anti-chlamydia antibiotic intervention pilot studies have renewed interest in the role of C. pneumoniae, and corroborated the evidence from sero-epidemiological, pathological and animal-model studies. The results of larger, on-going, purpose-designed intervention studies should help to increase our understanding of the role of infection in atherogenesis and potentially lead to a novel and effective treatment strategy for patients with CHD--broad spectrum antibiotics.
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Chronic Inflammation: Introduction
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease I: Introduction
Chronic Pancreatitis I: Introduction
Coronary Artery Disease III: Clinical Manifestations